Identification of Celecoxib-Targeted Proteins Using Label-Free Thermal Proteome Profiling on Rat Hippocampus
The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Recent innovations in solubility and stability alteration assays have revolutionized the study of drug-protein interactions (12, 13).”
From DORSSAA: Drug-Target interactOmics Resource Based on Stability/Solubility Alteration Assay (2026) · cites this paper as [13]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Piñero, J., Bravo, À., Queralt-Rosinach, N., Gutiérrez-Sacristán, A., Deu-Pons, J., Centeno, E., García-García, J., Sanz, F., & Furlong, L. I. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkw943 · Cited by 2,680
Mass-spectrometric exploration of proteome structure and function
Aebersold, R., & Mann, M. (2016) · Nature · doi:10.1038/nature19949 · Cited by 2,334
Monitoring Drug Target Engagement in Cells and Tissues Using the Cellular Thermal Shift Assay
Molina, D. M., Jafari, R., Ignatushchenko, M., Seki, T., Larsson, E. A., Dan, C., Sreekumar, L., Cao, Y., & Nordlund, P. (2013) · Science · doi:10.1126/science.1233606 · Cited by 2,261
Tracking cancer drugs in living cells by thermal profiling of the proteome
Savitski, M. M., Reinhard, F. B. M., Franken, H., Werner, T., Savitski, M. F., Eberhard, D., Molina, D. M., Jafari, R., Dovega, R. B., Klaeger, S., et al. (2014) · Science · doi:10.1126/science.1255784 · Cited by 1,187
Expansion of the Human Phenotype Ontology (HPO) knowledge base and resources
Köhler, S., Carmody, L., Vasilevsky, N., Jacobsen, J. O. B., Danis, D., Gourdine, J.-P., Gargano, M., Harris, N. L., Matentzoglu, N., McMurry, J. A., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gky1105 · Cited by 677
Neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease
Philips, T., & Robberecht, W. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70015-1 · Cited by 646
Morales, I., Guzmán-MartÃnez, L., Cerda-Troncoso, C., FarÃas, G. A., & Maccioni, R. B. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00112 · Cited by 490
Thermal profiling reveals phenylalanine hydroxylase as an off-target of panobinostat
Becher, I., Werner, T., Doce, C., Zaal, E. A., Tögel, I., Khan, C. A., Rueger, A., Muelbaier, M., Salzer, E., Berkers, C. R., et al. (2016) · Nature Chemical Biology · doi:10.1038/nchembio.2185 · Cited by 251
Haas, A. K., Yoshimura, S.-I., Stephens, D. J., Preisinger, C., Fuchs, E., & Barr, F. A. (2007) · Journal of Cell Science · doi:10.1242/jcs.014225 · Cited by 201
TISSUES 2.0: an integrative web resource on mammalian tissue expression
Palasca, O., Santos, A., Stolte, C., Gorodkin, J., & Jensen, L. J. (2018) · Database · doi:10.1093/database/bay003 · Cited by 182
Research works printed but not linked: 90
- Acharya, 2012, Neuronal PAD4 expression and protein citrullination: possible role in production of autoantibodies associated with neurodegenerative disease, J Autoimmun, 38, 369, 10.1016/j.jaut.2012.03.004 · DOI
- Agius, 2012, Neuroinflammation as the proximate cause of signature pathogenic pattern progression in amyotrophic lateral sclerosis, AIDS, and multiple sclerosis, Pathol Res Int, 2012, 10.1155/2012/169270 · DOI
- Akiyama, 2000, Inflammation and Alzheimer’s disease, Neurobiol Aging, 21, 383, 10.1016/S0197-4580(00)00124-X · DOI · Paper page
- Asial, 2013, Engineering protein thermostability using a generic activity-independent biophysical screen inside the cell, Nat Commun, 4, 2901, 10.1038/ncomms3901 · DOI
- Assefnia, 2014, Cadherin-11 in poor prognosis malignancies and rheumatoid arthritis: common target, common therapies, Oncotarget, 5, 1458, 10.18632/oncotarget.1538 · DOI
- Atukorala, 2013, Valdecoxib: the rise and fall of a COX-2 inhibitor, Expert Opin Pharmacother, 14, 1077, 10.1517/14656566.2013.783568 · DOI
- Bento, 2014, The ChEMBL bioactivity database: an update, Nucleic Acids Res, 42, D1083, 10.1093/nar/gkt1031 · DOI · Paper page
- Chen, 2013, Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool, BMC Bioinformatics, 14, 128, 10.1186/1471-2105-14-128 · DOI · Paper page
- Chia, 2009, Emerging roles for Rab family GTPases in human cancer, Biochim Biophys Acta, 1795, 110
- Chuang, 2008, COX-2 inhibition is neither necessary nor sufficient for celecoxib to suppress tumor cell proliferation and focus formation in vitro, Mol Cancer, 7, 38, 10.1186/1476-4598-7-38 · DOI
- Dannenberg, 2003, Targeting cyclooxygenase-2 in human neoplasia: rationale and promise, Cancer Cell, 4, 431, 10.1016/S1535-6108(03)00310-6 · DOI · Paper page
- Dembo, 2005, Central nervous system concentrations of cyclooxygenase-2 inhibitors in humans, Anesthesiology, 102, 409, 10.1097/00000542-200502000-00026 · DOI · Paper page
- Eikelenboom, 2004, Neuroinflammatory perspectives on the two faces of Alzheimer’s disease, J Neural Transm (Vienna), 111, 281, 10.1007/s00702-003-0055-1 · DOI · Paper page
- Eppig, 2017, Mouse Genome Informatics (MGI): resources for mining mouse genetic, genomic, and biological data in support of primary and translational research, Methods Mol Biol, 1488, 47, 10.1007/978-1-4939-6427-7_3 · DOI
- Fond, 2014, Effectiveness and tolerance of anti-inflammatory drugs’ add-on therapy in major mental disorders: a systematic qualitative review, Acta Psychiatr Scand, 129, 163, 10.1111/acps.12211 · DOI · Paper page
- Franken, 2015, Thermal proteome profiling for unbiased identification of direct and indirect drug targets using multiplexed quantitative mass spectrometry, Nat Protoc, 10, 1567, 10.1038/nprot.2015.101 · DOI · Paper page
- Gagliano Taliun, 2020, Exploring and visualizing large-scale genetic associations by using PheWeb, Nat Genet, 52, 550, 10.1038/s41588-020-0622-5 · DOI · Paper page
- Gaudet, 2011, Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium, Brief Bioinform, 12, 449, 10.1093/bib/bbr042 · DOI · Paper page
- Gilliam, 2013, Evaluation of anti-citrullinated type II collagen and anti-citrullinated vimentin antibodies in patients with juvenile idiopathic arthritis, Pediatr Rheumatol Online J, 11, 31, 10.1186/1546-0096-11-31 · doi:10.1186/1546-0096-11-31
- Goldstein, 2009, Inflammation and the phenomenology, pathophysiology, comorbidity, and treatment of bipolar disorder: a systematic review of the literature, J Clin Psychiatry, 70, 1078, 10.4088/JCP.08r04505 · DOI · Paper page
- Goncalves, 2010, The COX-2 inhibitors, meloxicam and nimesulide, suppress neurogenesis in the adult mouse brain, Br J Pharmacol, 159, 1118, 10.1111/j.1476-5381.2009.00618.x · DOI · Paper page
- Grösch, 2006, Cyclooxygenase-2 (COX-2)-independent anticarcinogenic effects of selective COX-2 inhibitors, J Natl Cancer Inst, 98, 736, 10.1093/jnci/djj206 · DOI · Paper page
- Guo, 2012, Temperature dependence of protein folding kinetics in living cells, Proc Natl Acad Sci USA, 109, 17863, 10.1073/pnas.1201797109 · DOI · Paper page
- György, 2006, Citrullination: a posttranslational modification in health and disease, Int J Biochem Cell Biol, 38, 1662, 10.1016/j.biocel.2006.03.008 · DOI · Paper page
- Hecker, 2012, SuperTarget goes quantitative: update on drug-target interactions, Nucleic Acids Res, 40, D1113, 10.1093/nar/gkr912 · DOI · Paper page
- Hirsch, 2003, The role of glial reaction and inflammation in Parkinson’s disease, Ann N Y Acad Sci, 991, 214, 10.1111/j.1749-6632.2003.tb07478.x · DOI · Paper page
- Hong, 2005, SNAREs and traffic. Biochimica et Biophysica Acta (BBA)-, Mol Cell Res, 1744, 120
- Jafari, 2019, Why, when and how to adjust your P values?, Cell J, 20, 604
- Jafari, 2013, Exploring biological processes involved in embryonic stem cell differentiation by analyzing proteomic data, Biochim Biophys Acta, 1834, 1063, 10.1016/j.bbapap.2013.02.003 · doi:10.1016/j.bbapap.2013.02.003
- Jafari, 2014, The cellular thermal shift assay for evaluating drug target interactions in cells, Nat Protoc, 9, 2100, 10.1038/nprot.2014.138 · DOI · Paper page
- Jarzab, 2020, Meltome atlas-thermal proteome stability across the tree of life, Nat Methods, 17, 495, 10.1038/s41592-020-0801-4 · DOI · Paper page
- Johnson, 2002, The cyclo-oxygenase-2 inhibitor celecoxib perturbs intracellular calcium by inhibiting endoplasmic reticulum Ca2+-ATPases: a plausible link with its anti-tumour effect and cardiovascular risks, Biochem J, 366, 831, 10.1042/bj20020279 · DOI
- Jones, 2001, Nonsteroidal anti-inflammatory drug prescribing: past, present, and future, Am J Med, 110, 4S, 10.1016/S0002-9343(00)00627-6 · doi:10.1016/s0002-9343(00)00627-6
- Kang, 2009, Enhanced sensitivity of celecoxib in human glioblastoma cells: induction of DNA damage leading to p53-dependent G1 cell cycle arrest and autophagy, Mol Cancer, 8, 66, 10.1186/1476-4598-8-66 · DOI
- Kashfi, 2005, Non-COX-2 targets and cancer: expanding the molecular target repertoire of chemoprevention, Biochem Pharmacol, 70, 969, 10.1016/j.bcp.2005.05.004 · DOI
- Kim, 2007, GADD153 mediates celecoxib-induced apoptosis in cervical cancer cells, Carcinogenesis, 28, 223, 10.1093/carcin/bgl227 · doi:10.1093/carcin/bgl227
- Koehne, 2004, COX-2 inhibition and colorectal cancer, Semin Oncol, 31, 12, 10.1053/j.seminoncol.2004.03.041 · DOI · Paper page
- Kurganov, 2002, Kinetics of thermal aggregation of tobacco mosaic virus coat protein, Biochemistry (Mosc), 67, 525, 10.1023/A:1015589926728 · DOI
- Kutmon, 2016, WikiPathways: capturing the full diversity of pathway knowledge, Nucleic Acids Res, 44, D488, 10.1093/nar/gkv1024 · DOI · Paper page
- Kwiatkowska, 2017, Status of etoricoxib in the treatment of rheumatic diseases. Expert panel opinion, Reumatologia, 55, 290, 10.5114/reum.2017.72626 · DOI
- Lahusen, 2018, BRCA1 function in the intra-S checkpoint is activated by acetylation via a pCAF/SIRT1 axis, Oncogene, 37, 2343, 10.1038/s41388-018-0127-1 · DOI
- Larance, 2015, Multidimensional proteomics for cell biology, Nat Rev Mol Cell Biol, 16, 269, 10.1038/nrm3970 · DOI · Paper page
- Li, 2016, Label-free technologies for target identification and validation, MedChemComm, 7, 769, 10.1039/C6MD00045B · DOI
- Lomenick, 2011, Target identification using drug affinity responsive target stability (DARTS), Curr Protoc Chem Biol, 3, 163, 10.1002/9780470559277.ch110180 · DOI · Paper page
- Luo, 2015, The Rab2A GTPase promotes breast cancer stem cells and tumorigenesis via Erk signaling activation, Cell Rep, 11, 111, 10.1016/j.celrep.2015.03.002 · DOI
- Marnett, 1999, Arachidonic acid oxygenation by COX-1 and COX-2. Mechanisms of catalysis and inhibition, J Biol Chem, 274, 22903, 10.1074/jbc.274.33.22903 · DOI · Paper page
- Masferrer, 2000, Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors, Cancer Res, 60, 1306
- Mateus, 2017, Thermal proteome profiling: unbiased assessment of protein state through heat-induced stability changes, Proteome Sci, 15, 13, 10.1186/s12953-017-0122-4 · DOI · Paper page
- McGeer, 2004, Inflammation and neurodegeneration in Parkinson’s disease, Parkinsonism Relat Disord, 10, S3, 10.1016/j.parkreldis.2004.01.005 · DOI · Paper page
- Nam, 2015, Comparison of pharmacological and genetic inhibition of cyclooxygenase-2: effects on adult neurogenesis in the hippocampal dentate gyrus, J Vet Sci, 16, 245, 10.4142/jvs.2015.16.3.245 · DOI
- Nickchi, 2015, PEIMAN 1.0: post-translational modification enrichment, integration and matching ANalysis, Database (Oxford), 2015, 10.1093/database/bav037 · DOI
- Onder, 2004, NSAID-related psychiatric adverse events: who is at risk?, Drugs, 64, 2619, 10.2165/00003495-200464230-00001 · DOI
- Pace, 1980, Substrate stabilization of lysozyme to thermal and guanidine hydrochloride denaturation, J Biol Chem, 255, 3862, 10.1016/S0021-9258(19)85604-1 · DOI · Paper page
- Paulson, 2001, Pharmacokinetics of celecoxib after oral administration in dogs and humans: effect of food and site of absorption, J Pharmacol Exp Ther, 297, 638, 10.1016/S0022-3565(24)29580-X · DOI · Paper page
- Pei, 2007, Proteome analysis and tissue microarray for profiling protein markers associated with lymph node metastasis in colorectal cancer, J Proteome Res, 6, 2495, 10.1021/pr060644r · DOI
- Perazella, 2001, Selective cyclooxygenase-2 inhibitors: a pattern of nephrotoxicity similar to traditional nonsteroidal anti-inflammatory drugs, Am J Med, 111, 64, 10.1016/S0002-9343(01)00757-4 · DOI · Paper page
- Petsko GA, Ringe D (2004) Protein structure and function, New Science Press.
- Piran, 2020, Can we assume the gene expression profile as a proxy for signaling network activity?, Biomolecules, 10, 850, 10.3390/biom10060850 · DOI · Paper page
- Pyrko, 2007, Calcium-activated endoplasmic reticulum stress as a major component of tumor cell death induced by 2,5-dimethyl-celecoxib, a non-coxib analogue of celecoxib, Mol Cancer Ther, 6, 1262, 10.1158/1535-7163.MCT-06-0629 · DOI
- Rahme, 2007, Hospitalization for gastrointestinal bleeding associated with non-steroidal anti-inflammatory drugs among elderly patients using low-dose aspirin: a retrospective cohort study, Rheumatology (Oxford), 46, 265, 10.1093/rheumatology/kel223 · DOI
- Reckzeh, 2019, Target engagement of small molecules: thermal profiling approaches on different levels, Methods Mol Biol, 1888, 73, 10.1007/978-1-4939-8891-4_4 · DOI
- Reinhard, 2015, Thermal proteome profiling monitors ligand interactions with cellular membrane proteins, Nat Methods, 12, 1129, 10.1038/nmeth.3652 · DOI · Paper page
- Sams-Dodd, 2005, Target-based drug discovery: is something wrong?, Drug Discov Today, 10, 139, 10.1016/S1359-6446(04)03316-1 · DOI · Paper page
- Schenone, 2013, Target identification and mechanism of action in chemical biology and drug discovery, Nat Chem Biol, 9, 232, 10.1038/nchembio.1199 · DOI · Paper page
- Schmidt, 2010, GSK/Sirtris compounds dogged by assay artifacts, Nat Biotechnol, 28, 185, 10.1038/nbt0310-185 · DOI
- Schönthal, 2007, Direct non-cyclooxygenase-2 targets of celecoxib and their potential relevance for cancer therapy, Br J Cancer, 97, 1465, 10.1038/sj.bjc.6604049 · DOI · Paper page
- Scifo, 2015, Proteomic analysis of the palmitoyl protein thioesterase 1 interactome in SH-SY5Y human neuroblastoma cells, J Proteomics, 123, 42, 10.1016/j.jprot.2015.03.038 · DOI
- Skuta, 2017, Probes & Drugs portal: an interactive, open data resource for chemical biology, Nat Methods, 14, 759, 10.1038/nmeth.4365 · DOI
- Smith, 2000, Cyclooxygenases: structural, cellular, and molecular biology, Annu Rev Biochem, 69, 145, 10.1146/annurev.biochem.69.1.145 · DOI · Paper page
- Strickland, 2013, Thermodynamic analysis of protein-ligand binding interactions in complex biological mixtures using the stability of proteins from rates of oxidation, Nat Protoc, 8, 148, 10.1038/nprot.2012.146 · DOI
- Swinney, 2013, Phenotypic vs. target-based drug discovery for first-in-class medicines, Clin Pharmacol Ther, 93, 299, 10.1038/clpt.2012.236 · DOI · Paper page
- Tanaka, 2005, Involvement of intracellular Ca2+ levels in nonsteroidal anti-inflammatory drug-induced apoptosis, J Biol Chem, 280, 31059, 10.1074/jbc.M502956200 · DOI
- Tang, 2018, Drug target commons: a community effort to build a consensus knowledge base for drug-target interactions, Cell Chem Biol, 25, 224, 10.1016/j.chembiol.2017.11.009 · DOI · Paper page
- Tanoli, 2018, Drug Target Commons 2.0: a community platform for systematic analysis of drug-target interaction profiles, Database (Oxford), 2018, 1, 10.1093/database/bay083 · DOI · Paper page
- Terzi, 2018, The use of non-steroidal anti-inflammatory drugs in neurological diseases, J Chem Neuroanat, 87, 12, 10.1016/j.jchemneu.2017.03.003 · DOI
- Tzeng, 2016, Rab-mediated vesicle trafficking in cancer, J Biomed Sci, 23, 70, 10.1186/s12929-016-0287-7 · DOI · Paper page
- Ungermann, 2005, Functions of SNAREs in intracellular membrane fusion and lipid bilayer mixing, J Cell Sci, 118, 3819, 10.1242/jcs.02561 · DOI
- Usman, 2014, Heat shock proteins: functions and response against heat stress in plants, Int J Sci Technol Res, 3, 204
- Vedadi, 2006, Chemical screening methods to identify ligands that promote protein stability, protein crystallization, and structure determination, Proc Natl Acad Sci USA, 103, 15835, 10.1073/pnas.0605224103 · DOI · Paper page
- Wang, 2004, Effect of celecoxib on Ca2+ movement and cell proliferation in human osteoblasts, Biochem Pharmacol, 67, 1123, 10.1016/j.bcp.2003.11.004 · doi:10.1016/j.bcp.2003.11.004
- Wang, 2017, Celecoxib-induced inhibition of neurogenesis in fetal frontal cortex is attenuated by curcumin via Wnt/β-catenin pathway, Life Sci, 185, 95, 10.1016/j.lfs.2017.07.028 · DOI
- West, 2008, Thermodynamic analysis of protein stability and ligand binding using a chemical modification- and mass spectrometry-based strategy, Anal Chem, 80, 4175, 10.1021/ac702610a · DOI · Paper page
- West, 2010, Quantitative proteomics approach for identifying protein-drug interactions in complex mixtures using protein stability measurements, Proc Natl Acad Sci USA, 107, 9078, 10.1073/pnas.1000148107 · DOI · Paper page
- Wishart, 2018, DrugBank 5.0: a major update to the DrugBank database for 2018, Nucleic Acids Res, 46, D1074, 10.1093/nar/gkx1037 · DOI · Paper page
- Wiśniewski, 2009, Universal sample preparation method for proteome analysis, Nat Methods, 6, 359, 10.1038/nmeth.1322 · DOI · Paper page
- Wongrakpanich, 2018, A comprehensive review of non-steroidal anti-inflammatory drug use in the elderly, Aging Dis, 9, 143, 10.14336/AD.2017.0306 · DOI · Paper page
- Yaksh, 2001, The acute antihyperalgesic action of nonsteroidal, anti-inflammatory drugs and release of spinal prostaglandin E2 is mediated by the inhibition of constitutive spinal cyclooxygenase-2 (COX-2) but not COX-1, J Neurosci, 21, 5847, 10.1523/JNEUROSCI.21-16-05847.2001 · DOI · Paper page
- Zagidullin, 2019, DrugComb: an integrative cancer drug combination data portal, Nucleic Acids Res, 47, W43, 10.1093/nar/gkz337 · DOI · Paper page
- Zhao, 2007, Cellular functions of NSF: not just SNAPs and SNAREs, FEBS Lett, 581, 2140, 10.1016/j.febslet.2007.03.032 · DOI · Paper page
- Zhou, 2016, Lysine acetylation stabilizes SP2 protein in the silkworm Bombyx mori, J Insect Physiol, 91–92, 56, 10.1016/j.jinsphys.2016.06.008 · DOI
Cited by
DORSSAA: Drug-Target interactOmics Resource Based on Stability/Solubility Alteration Assay
Zangene, E., Gholizadeh, E., Schwämmle, V., Saei, A. A., Wilhelm, M., Käll, L., & Jafari, M. (2026) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2026.101603 · Cited by 3
Self-citation
Metadata
- Authors
- Gholizadeh, E., Karbalaei, R., Khaleghian, A., Salimi, M., Gilany, K., Soliymani, R., Tanoli, Z., Rezadoost, H., Baumann, M., Jafari, M., & Tang, J.
- Venue
- Molecular Pharmacology
- Publisher
- Elsevier BV
- Published
- 2021-05
- Volume
- 99
- Issue
- 5
- Pages
- 308-318
- ISSN
- 0026-895X
- Cited by
- 18
- References
- 12
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 1341 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Identification of Celecoxib-Targeted Proteins Using Label-Free Thermal Proteome Profiling on Rat Hippocampus. https://app.cochat.ai/papers/10.1124/molpharm.120.000210
- The paper
- Gholizadeh, E., Karbalaei, R., Khaleghian, A., Salimi, M., Gilany, K., Soliymani, R., Tanoli, Z., Rezadoost, H., Baumann, M., Jafari, M., & Tang, J. (2021). Identification of Celecoxib-Targeted Proteins Using Label-Free Thermal Proteome Profiling on Rat Hippocampus. Molecular Pharmacology. https://doi.org/10.1124/molpharm.120.000210
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.